TNF Receptor, Extracellular Domain p55, Recombinant, Human (TNFR 1, CD120a, MGC19588, p55, p55 R, TNFR55, Tumor Necrosis Factor alpha Receptor, Tumor Necrosis Factor Binding Protein 1, TBP1, Tumor Necrosis Factor Receptor Superfamily Member 1A, TNFRSF1a)

Catalog No : USB-T9161-06N
513.81€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name TNF Receptor, Extracellular Domain p55, Recombinant, Human (TNFR 1, CD120a, MGC19588, p55, p55 R, TNFR55, Tumor Necrosis Factor alpha Receptor, Tumor Necrosis Factor Binding Protein 1, TBP1, Tumor Necrosis Factor Receptor Superfamily Member 1A, TNFRSF1a)
Catalog No USB-T9161-06N
Supplier’s Catalog No T9161-06N
Supplier US Biologicals
Source antigen Recombinant, Sf9
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -70°C
Other names
Grade Purified
Purity Purified. ≥ 80% pure. Three bands are observed by SDS gel electrophoresis.
Form Supplied as a lyophilized powder in PBS, 10mM Hepes, pH 7.0
Reactivity life 6 months
Note For reserch purpose only
Purity Purified. ≥ 80% pure. Three bands are observed by SDS gel electrophoresis.
Description The immunoregulatory cytokine tumor necrosis factor alpha (TNFa) recognizes two cell surface receptors. TNF-R1 (also known as CD120a) has an apparent molecular mass of 55/60kD and is constitutively expressed on all nucleated cells, whereas TNF R2 (also known as CD120b) with an apparent molecular mass of 75/80kD, is restricted to hematopoietic cells. TNF-R2 directs TNFa mediated activation and proliferation of T lymphocytes. An autocrine role for TNF and TNF-R2 is implicated in hematopoietic malignancies, and the TNF-R2 locus is a translocation target in several leukemias, suggesting a role for TNF-R2 in the development of certain leukemias. The p55 receptor extracellular domain was produced in insect cells (Sf9) infected with recombinant viruses. Source: Sf9 Biological Activity: Binding of the ligand TNF was demonstrated by receptor binding competition of binding with radioactive TNF. Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute to with sterile dH2O or buffer, aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.